Dyslipidemia in northeastern China

Central European Journal of Medicine

Volumn 6, Issue 2, 2011, Pages 220-226

  Shi, Xiao Dong ^a   Jin, Qinglong ^a   Hu, Yulin ^a   Chi, Xiumei ^a   Gao, Yanhang ^a   Tao, Yuchun ^b   Sun, Jie ^a   Niu, Jun Qi ^a  

^a THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Hyperaldosteronism; Hypokalemic myopathy; Licorice; Renal damage

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BODY MASS; CHINA; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; EDUCATIONAL STATUS; EXERCISE; FATTY LIVER; FEMALE; HEALTH EDUCATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 79956361556     PISSN: 18951058     EISSN: 16443640     Source Type: Journal    
DOI: 10.2478/s11536-010-0075-9     Document Type: Article

References (35)

1. Guilbert JJ. The world health report 2002 - reducing risks, promoting healthy life. Educ Health (Abingdon) 2003,16,230
2. He J, Gu D, Reynolds K, Wu X, Muntner P, Zhao J, et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China. Circulation 2004,110,405-11 (Pubitemid 38993849)
3. Khashayar P, Mohagheghi A. The correlation between dyslipidemia and coronary artery disease based on angiographic findings in an Iranian population. Acta Med Indones 2010,42,82-5
4. Lei ZM, Ye MX, Fu WG, Chen Y, Fang C, Li J. Levels of serum leptin, cholecystokinin, plasma lipid and lipoprotein. Hepatobiliary Pancreat Dis Int 2008,7,65-9. PMID, 18234641
5. Wang Y. Surgical treatment of portal hypertension. Hepatobiliary Pancreat Dis Int 2002,1,211-4 (Pubitemid 36748204)
6. Nishida C, Uauy R, Kumanyika S, Shetty P. The oint WHO/FAO expert consultation on diet, nutrition and the prevention of chronic diseases, process, product and policy implications. Public Health Nutr 2004,7,245-50 (Pubitemid 38294520)
7. China, long-term issues and options in the health transition.ed. Washington, D.C. , World Bank, 1992,1-3
8. Zhang L, Qin LQ, Liu AP, Wang PY. Prevalence of risk factors for cardiovascular disease and their associations with diet and physical activity in suburban Beijing, China. J Epidemiol 2010,20,237-43
9. Obesity:preventing and managing the global epidemic, report of a WHO consultation.ed. Geneva ,World Health Organization,1997,8-11
10. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 2005,366,1059-62 (Pubitemid 41338752)
11. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of nonalcoholic fatty liver disease. Zhonghua Gan Zang Bing Za Zhi 2003,11,71
12. Fatty Liver and Alcoholic Liver Disease Study Group of Chinese Liver Disease Association. Diagnostic criteria of alcoholic liver disease. Zhonghua Gan Zang Bing Za Zhi 2003,11,72
13. Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi 2007,35,390-419
14. Fuentes R, Uusitalo T, Puska P, Tuomilehto J, Nissinen A. Blood cholesterol level and prevalence of hypercholesterolaemia in developing countries, a review of population-based studies carried out from 1979 to 2002. Eur J Cardiovasc Prev Rehabil 2003,10,411-9
15. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA 1987,257,2176-80 (Pubitemid 17055840)
16. Tao SC, Li YH, Xiao ZK, Cen RC, Zhang HY, Zhuo YL, et al. Serum lipids and their correlates in Chinese urban and rural populations of Beijing and Guangzhou. Int J Epidemiol 1992,21,893-903
17. Li Z, Yang R, Xu G, Xia T. Serum lipid concentrations and prevalence of dyslipidemia in a large professional population in Beijing. Clin Chem 2005,51,144-50 (Pubitemid 40024024)
18. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM). Results of follow-up at 8 years. Eur Heart J 1998,19 Suppl A,A2-11 (Pubitemid 28112471)
19. Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs, evidence from a national cross sectional survey. BMJ 2000,321,1322-5
20. Johnson CL, Rifkind BM, Sempos CT, Carroll MD, Bachorik PS, Briefel RR, et al. Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys. JAMA 1993,269,3002-8 (Pubitemid 23164343)
21. Gupta R, Gupta VP, Sarna M, Bhatnagar S, Thanvi J, Sharma V, et al. Prevalence of coronary heart disease and risk factors in an urban Indian population, Jaipur Heart Watch-2. Indian Heart J 2002,54,59-66
22. Chang HY, Yeh WT, Chang YH, Tsai KS, Pan WH. Prevalence of dyslipidemia and mean blood lipid values in Taiwan, results from the Nutrition and Health Survey in Taiwan (NAHSIT, 1993-1996). Chin J Physiol 2002,45,187-97
23. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998,81,7B-12B (Pubitemid 28113939)
24. Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P, et al. Serum lipid levels in an Iranian adults population, Tehran Lipid and Glucose Study. Eur J Epidemiol 2003,18,311-9. PMID, 12803371 (Pubitemid 36612894)
25. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000,8,605-19
26. Ornish D, Scherwitz LW, Billings JH, Brown SE, Gould KL, Merritt TA, et al. Intensive lifestyle changes for reversal of coronary heart disease. JAMA 1998,280,2001-7 (Pubitemid 28562678)
27. Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease, predicting risks by levels and ratios. Ann Intern Med 1994,121,641-7
28. Biddinger SB, Hernandez-Ono A, Rask-Madsen C, Haas JT, Aleman JO, Suzuki R, et al. Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab 2008,7,125-34 (Pubitemid 351168555)
29. Lussier-Cacan S, Bolduc A, Xhignesse M, Niyonsenga T, Sing CF. Impact of alcohol intake on measures of lipid metabolism depends on context defined by gender, body mass index, cigarette smoking, and apolipoprotein E genotype. Arterioscler Thromb Vasc Biol 2002,22,824-31 (Pubitemid 34517796)
30. Brown CD, Higgins M, Donato KA, Rohde FC, Garrison R, Obarzanek E, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 2000,8,605-19
31. Primatesta P, Poulter NR. Lipid concentrations and the use of lipid lowering drugs, evidence from a national cross sectional survey. BMJ 2000,321,1322-5
32. Lorenzo C, Serrano-Rios M, Martinez-Larrad MT, Gabriel R, Williams K, Gonzalez-Villalpando C, et al. Prevalence of hypertension in Hispanic and non-Hispanic white populations. Hypertension 2002,39,203-8 (Pubitemid 34165215)
33. de Souza LJ, Souto FJ, de Souza TF, Reis AF, Gicovate NC, Bastos DA, et al. Prevalence of dyslipidemia and risk factors in Campos dos Goytacazes, in the Brazilian state of Rio de Janeiro. Arq Bras Cardiol 2003,81,249-64 (Pubitemid 37242988)
34. Yarnell J, Yu S, McCrum E, Arveiler D, Hass B, Dallongeville J, et al. Education, socioeconomic and lifestyle factors, and risk of coronary heart disease, the PRIME Study. Int J Epidemiol 2005,34,268-75 (Pubitemid 40645311)
35. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001,285,2486-97